News Releases

News Releases
Events
Presentations

Year

August 6, 2025

Bioventus Reports Second Quarter Financial Results

Q2 reported revenue of $147.7 million declined 2.4% ; Organic* revenue advanced 6.2% Second quarter diluted earnings per share was $0.11 compared to a diluted loss per share of $0.40 in the prior-year period Non-GAAP earnings* of $0.21 per share increased 31% Cash from operations of $25.9 million

August 4, 2025

Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity

DURHAM, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has entered into a $400 million Senior Secured Credit Agreement (the “Credit Agreement”) consisting of a $300

July 30, 2025

Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products

DURHAM, N.C., July 30, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, announced today a significant milestone with the U.S. Food and Drug Administration (FDA) 510(k) clearances for both TalisMann™ and StimTrial™, expanding the Company’s

July 29, 2025

Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025

DURHAM, N.C., July 29, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”) , a global leader in innovations for active healing, today announced that it will report financial results for the second quarter of fiscal year 2025 before the market opens on Wednesday,

May 6, 2025

Bioventus Reports First Quarter Financial Results

Q1 reported revenue of $123.9 million declined 4.3% ; Organic* revenue advanced 5.0% First quarter net loss was $0.04 per share compared to a loss of $0.08 in the prior-year period Non-GAAP earnings* of $0.08 per share increased 33% Company reiterated revenue, Adjusted EBITDA* and Non-GAAP EPS*

April 28, 2025

Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025

DURHAM, N.C., April 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”) , a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal year 2025 before the market opens on Tuesday, May

March 11, 2025

Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results

Accelerated fourth quarter sales growth to 13.5% Fourth quarter gross margin expanded 310 bps and adjusted gross margin* expanded 230 bps Fourth quarter cash from operations of $19.3 million increased 86.3% Provides full-year 2025 financial guidance reflecting continued above market revenue growth

February 28, 2025

Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025

DURHAM, N.C., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2024 before the market opens on Tuesday, March

January 7, 2025

Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference

DURHAM, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, chief executive officer, will present at the 43 rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 10:30

January 2, 2025

Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

DURHAM, N.C., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has successfully completed the divestiture of its Advanced Rehabilitation business to Accelmed Partners

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Displaying 11 - 20 of 146